Patients with moderate hemophilia express varying bleeding phenotypes. To assess the burden of disease...
Read More
Adolescents with hemophilia are a patient population with special requirements, having to manage their...
Hemophilia is a rare congenital bleeding disorder that results from complete or partial deficiency...
Deficiencies of factor VIII (FVIII)/von Willebrand factor (VWF) or factor IX (FIX) are underappreciated ...
With recent approval of the first two gene therapies for haemophilia A and B,...
Hemophilia B (HB) is a rare, hereditary disease caused by a defect in the...
The advent of new treatment options over the last decades has markedly improved the...
Thromboembolic events are increasingly reported in the aging haemophilia population. The purpose of this...
Haemophilia treatment centres (HTCs) and healthcare providers (HCPs) will need to adapt to a...
Recent recommendations of core outcome sets for haemophilia highlight the need for including measures...